Skip to Main Content

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is quite modest this time around. We plan to tend to the Pharmalot campus grounds, spend time with our short person, and catch up on some reading. And what about you? As we have noted previously, this is a lovely time of year to enjoy the great outdoors. You could make time to see someone special or undertake some spring cleaning. And for the adventurous, you could place wagers on whether President Trump proposes anything transformative in his upcoming speech on drug prices. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Opioid makers are preparing to take their chances in court rather than pay billions of dollars to settle lawsuits blaming them for addictions, Bloomberg News reports. With the first trial just 10 months away, the companies are counting on narrowing or defeating lawsuits by numerous states, cities, and counties, which would slash or eliminate settlement costs. “It would make no sense for the companies to start talking about money until the strength of those defenses are tested in court,” says Adam Zimmerman, a professor at Loyola Law School. But it they fail, the cost of a deal could rise.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!